India Biologics Regulatory Affairs Outsourcing Market Size & Outlook
India biologics regulatory affairs outsourcing market, 2018-2030 (US$M)
Related Markets
India biologics regulatory affairs outsourcing market highlights
- The India biologics regulatory affairs outsourcing market generated a revenue of USD 132.8 million in 2023 and is expected to reach USD 276.5 million by 2030.
- The India market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, regulatory writing & publishing was the largest revenue generating services in 2023.
- Legal Representation is the most lucrative services segment registering the fastest growth during the forecast period.
Biologics regulatory affairs outsourcing market data book summary
| Market revenue in 2023 | USD 132.8 million |
| Market revenue in 2030 | USD 276.5 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Regulatory writing & publishing |
| Fastest growing segment | Legal Representation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Regulatory Submissions, Regulatory Operations, Other Services, Regulatory Consulting |
| Key market players worldwide | Accell, Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, PAREXEL, Freyr Solutions, PharmaLex, Pharmexon, QVigilance, BlueReg Group, Real Regulatory, PrimeVigilance Ltd., ProPharma Group, Regulatory Pharma Net, ZEINCRO Group, Biomapas, Dr. Regenold GmbH |
Other key industry trends
- In terms of revenue, India accounted for 6.4% of the global biologics regulatory affairs outsourcing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China biologics regulatory affairs outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 276.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Regulatory Affairs Outsourcing Market Scope
Biologics Regulatory Affairs Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India biologics regulatory affairs outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 25.6% in 2023. Horizon Databook has segmented the India biologics regulatory affairs outsourcing market based on legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services, regulatory consulting covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to India biologics regulatory affairs outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India biologics regulatory affairs outsourcing market databook
-
Our clientele includes a mix of biologics regulatory affairs outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India biologics regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into India biologics regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India biologics regulatory affairs outsourcing market size, by services, 2018-2030 (US$M)
India Biologics Regulatory Affairs Outsourcing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
